Cancer touches countless families, but few diagnoses carry the same fear as pancreatic cancer. Often discovered only after it has spread, the disease remains one of the deadliest forms of cancer and has frustrated researchers for decades.
Now, a new study is giving doctors and patients reason for optimism. According to research led by the University of California, Los Angeles (UCLA) and reported by CNN, an experimental drug called daraxonrasib has delivered some of the most encouraging results seen in years for advanced pancreatic cancer, reports Medonet.
A promising discovery
Scientists developed daraxonrasib to target KRAS mutations, genetic changes that drive the growth of most pancreatic cancers. These mutations have long been considered one of the toughest challenges in cancer research.
The drug works by blocking the signals that help cancer cells survive and spread. Researchers believe this targeted approach could open the door to more effective treatments for patients with limited options.
Also read: Cancer symptoms many people overlook in everyday life
Patients living longer
The clinical trial involved around 500 patients whose cancer no longer responded to standard therapies. Participants either received the experimental pill or additional chemotherapy.
The findings were striking. Patients treated with daraxonrasib survived an average of 13.2 months, compared with 6.7 months for those receiving chemotherapy. Researchers also reported fewer severe side effects and improvements in quality of life among many patients taking the new drug.
What comes next?
Health regulators in the United States have already begun an accelerated review of the treatment. Scientists are also investigating whether the drug could help patients diagnosed at earlier stages of the disease.
While experts stress that daraxonrasib is not a cure, many believe it could represent one of the most significant advances in pancreatic cancer treatment in recent years. For patients facing one of medicine’s most difficult diagnoses, that progress alone offers a powerful reason for hope.
Also read: Arthritis drug could become a new treatment for patients with depression
Sources: Medonet
Also read: WHO lowers number of suspected Ebola cases
This article is made and published by Mie Hermansen, who may have used AI in the preparation.